Viewing StudyNCT00433017



Ignite Creation Date: 2024-05-05 @ 5:19 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00433017
Status: TERMINATED
Last Update Posted: 2011-04-21
First Post: 2007-02-08

Brief Title: Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration AMD
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Choroidal Neovascularization
Macular Degeneration
Keywords:
Name View
Ranibizumab View
Age-related macular degeneration View
AMD View
Choroidal neovascularization View
Verteporfin View